- The regulation leading to the attestation is not yet in force, according to the Ordre’s publications.
- Only holders of the master’s in advanced pharmacotherapy will be able to obtain it.
- It will not allow prescribing a designated substance.
Who will be able to obtain the attestation?
The guide states that only holders of a master’s degree in advanced pharmacotherapy will be able to obtain it, and that the details will be set out in a future regulation.
What will it allow?
Once the regulation is in force, a pharmacist holding it may, beyond the situations already provided for, prescribe to treat a disease diagnosed by an authorized professional, or a frequent problem with typical signs that improves with time-limited treatment. If it falls within their competence, they could prescribe when the patient’s condition is unstable or the risks are higher.
What will it not change?
It will not authorize prescribing a designated substance, according to the guide. The pharmacist must also continue to stay within their competence, record, follow up and refer the patient as needed.
What to do in the meantime?
The guide invites pharmacists to know their colleagues’ competencies, including those holding this master’s degree, so they can refer patients to them or collaborate. Check the current status with the Ordre.
Sources: OPQ, summary of what is new (in French) · OPQ, practice guide on professional activities (in French) · OPQ, practice guide on professional activities (in French) · OPQ, practice guide on prescribing (in French)
General information based on the publications cited. This text does not replace professional or legal advice, or the Ordre’s guides.